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Summary
Purpose: We report long-term effects of vagus nerve stimulation (VNS) on epilepti-
form activity in 15 children, and how these changes are related to activity stage and to
clinical effects on seizure reduction, seizure severity (NHS3) and quality of life (QOL).
Methods: Initially, and after 3 and 9 months of VNS-treatment, 15 children were
investigated with 24 h ambulatory EEG monitoring for spike detection. The number of
interictal epileptiform discharges (IEDs) and the inter spike intervals (ISIs) were
analysed during 2 h in the awake state, and 1 h of rapid eye movement (REM)-,
spindle- and delta-sleep, respectively. Total number and duration of electrographic
seizure episodes were also analysed.
Results: At 9 months the total number of IEDs was significantly reduced ( p = 0.04).
There was a tendency of reduction in all activity stages, and significantly so in delta-
sleep ( p = 0.008). Total electrographic seizure number was significantly reduced in
the 24 h EEG at 3 and 9 months ( p = 0.03, 0.05). There was a significant concordance
in direction of changes in epileptiform activity and electrographic seizures at 9
months ( p = 0.04). Concordance in direction of changes was seen in 9 of 15 children
between clinical seizures and IED ( p > 0.3), in 10 of 15 children between QOL and IED
( p = 0.3) and in 8 of 15 children between NHS3 and IED ( p > 0.3). There was no direct
correlation between the extent of improvement in these clinical data and the degree
of spike reduction.
Conclusion: This study shows that VNS reduces IEDs especially in REM and delta sleep,
as well as the number of electrographic seizures. It also shows a concordance between
reduction in IEDs and electrographic seizures.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +46 46173377.
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Repetitive vagus nerve stimulation (VNS) is a neu-
rophysiologic method for treatment of refractory
epilepsy. VNS has proved to be efficacious and well
tolerated in adults.1,2
Paediatric studies have shown even better and
more rapid response. More than 50% seizure reduc-
tion was reported in 27—57% of the children. Inter-
estingly, these uncontrolled open studies also
showed a dramatic improvement in well-being
and quality of life (QOL).3—6 The most commonly
used parameter for evaluation of the efficacy of an
anti-epileptic treatment is clinical seizure fre-
quency. However, in this group of children with
therapy-resistant epilepsy and developmental
impairment, seizures can be subtle and difficult
to distinguish from other behavioural abnormalities.
An accurate seizure registration may therefore be
difficult to attain. Quantification of epileptiform
activity in long-term digital EEG recordings is one
way to assess effects and to elucidate the influence
of VNS on cerebral function.7—10
Over the past several years VNS has been shown
in several animal studies to suppress both ictal and
interictal epileptiform EEG activity. Zanchetti and
Chase showed induced synchronization and desyn-
chronization of the background EEG, depending on
the stimulus frequency and stimulation inten-
sity.11—13 Human studies have not been able to
reveal such changes.14,15 Until recently the only
documented acute effect of VNS in humans has
been occasional observations of abrupt termina-
tion of ictal events with VNS.15 Olejniczak et al.16
reported, in a case study, an immediate VNS effect
with significant decrease in epileptiform sharp
waves recorded directly from invasive EEG in the
left hippocampus despite absence of a clinical VNS
effect. Koo has shown that VNS does cause EEG
changes over time, and Kuba has shown an immedi-
ate effect on interictal and ictal epileptiform dis-
charges.17,18
When analysing EEG, spontaneous fluctuations in
the frequency of epileptiform discharges is a pro-
blem described both in anti-epileptic drug studies19
and in routine EEG recordings.20 A short EEG record-
ing may not be sufficient. A greater consistency of
the epileptiform activity is seen in long-term EEG
monitoring, including different stages of sleep.21
Binnie22 described transitory cognitive impairments
(TCI) produced by subclinical EEG IEDs, and empha-
sized the need for testing the relation between
psychosocial function and reduction of IEDs.
We report long-term effects of VNS on epilepti-
form activity in 15 children with medically refrac-
tory epilepsy, and how these changes are related toactivity stage and to clinical effects on seizure
reduction, seizure severity and effects on QOL.Methods
Subjects
The study group comprises 15 children (10 boys and
5 girls) aged 4—17 years (median 11 years) with the
diagnosis of therapy-resistant epilepsy with devel-
opmental impairment and absence of non-epileptic
seizures. Epilepsy surgery had been performed in
four patients and found not applicable in the others.
Age of epilepsy onset was between 4 months and 9
years (median 3 years). The duration of epilepsy was
4—12 years (median 8.5 years). The aetiology was
cortical dysplasia in five, encephalitis in one and
hypoxic ischemic encephalopathy in five. The aetiol-
ogy was unknown in four subjects. One showed right
anterior hippocampus atrophy, and in three there
were no MRI abnormalities. All patients had been on
stable anti-epileptic drug medication for at least 3
months prior to the VNS implantation and during the
9 months of follow-up. Written informed consent
was obtained. The study was accepted by the Ethics
Committee of the Faculty of Medicine of the Lund
University.
VNS
Vagus nerve stimulation is delivered via the Neuro
Cybernetic Prosthesis (NCP) System, Cyberonics,
Inc. The NCP is an implantable, multi-programmable
pulse generator that delivers current electrical sti-
mulation to the vagus nerve. The VNS can be pro-
grammed externally and individually. It can also be
activated by a hand-held magnet.
The vagus nerve stimulator is implanted subcu-
taneously below the clavicle on the left side. At the
end of the surgical procedure the device is pro-
grammed with the following parameters: output
current 0.25 mA; signal frequency 30 Hz; pulse-
width 500 ms; stimulation on-time 30 s; stimulation
off-time 5 min. During the initial 4 weeks, the out-
put current is increased in steps of 0.25 mA to 1—
1.5 mA and is then kept stable during the 9 months
of follow-up.
EEG monitoring
Continuous EEG recordings were performed during
24 h initially, and after 3 and 9 months of VNS-
treatment. The recording was ambulatory, with
the children in their natural surroundings. Twenty-
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enough artefact-free data and over-night sleep
recording for quantification of sleep. Meals, naps,
other activities, time of sleep and seizure events
were registered in a diary.
Via the Embla1 A10 Flaga-Medcare digital data
recorder, using sampling rate 200 Hz with 16 bits
resolution, data were recorded on a PCMCIA memory
flash card. The EEG was recorded with 11 scalp
electrodes and a referential electrode (F3, F4, C3,
C4, T3, T4, P3, P4, O1, O2, CZ, Ref.) according to the
10—20 International System. An additional electrode
wasapplied to the left side of thepatient’s neck, over
Erb’s point, with a corresponding reference on the
right side, to pick up the stimulus artefacts from the
stimulation electrodes of the NCP device. The digi-
talized data were converted to Nervus Tauragreining
EEG format (Valor format).
The epileptiform activity was counted in compar-
able assessment periods according to time of day
and activity stage. Two hours of artefact-free EEG
was selected from wake and 1 h of artefact-free EEG
was selected from three different sleep stages,
defined as rapid eye movement (REM), non-REM
(NREM) with theta activity and sleep spindles (ss)
and <50% slow wave sleep and delta-sleep (>50%
slow wave sleep). Periods of sleep during daytime,
seizure events or disturbances in the recordings due
to movement artefacts or technical problems were
not selected. For three children, selected channels
with continuous artefacts were excluded.
The spike counting was based on the Persyst1
Spike Detector version 3.0. In order to justify the
use of automatic spike detection, a single blind pilot
study comparing visual detection and the Persyst1
Spike Detector system was performed. We analysed
seven children encompassing altogether 21 h of EEG.
A Common Average montage was used. The visual
identification of epileptiform activity was performed
with a 5 Hz high pass filter and a 50 Hz low pass filter
in consecutive 10 s periods. Each solitary spike or
sharp wave with peak amplitude at least twice the
local background activity was supplied with an event
mark. The automatic spike detection was performed
in its most sensitive setting. All events were visually
evaluated and edited for false detections.
The total number of epileptiform discharges and
the inter-spike interval determined on each assess-
ment in the four activity stages were used for
comparison. The recording before VNS initiation
was used as baseline and compared with those at
3 and 9 months after VNS initiation.
We also compared seizure pattern as number and
duration of clinical, electrographic and combined
clinical and electrographic seizures. An electro-
graphic seizure event was defined as an abrupt onsetof rhythmic epileptiform activity of >10 s duration.
The whole material was visually analyzed, and no
software for automated electrographic seizure
detection was used.
During 3 months before initiation, a diary of
seizure frequency and severity was collected
together with clinical data. Follow-up assessments
were performed at 3 and 9 months after VNS initia-
tion. The types of seizures, epilepsies and epileptic
syndromes were defined according to the classifica-
tion of the International League Against Epilepsy,
including seizure semiology and electroencephalo-
gram characteristics before study entry.23,24 The
severity of the seizures was scored with the National
Hospital Seizure Severity Scale (NHS3), a further
development of the Chalfont Seizure Severity Scale
described by O’Donoghue et al.25 QOL was assessed
by a visual analogue scale. These data are reported
in another article.26
Statistical evaluation
The pilot study, i.e. the comparison between manual
visual inspection and the Persyst1 Spike Detector
system, was single blinded, i.e. the scorer was kept
blinded to the identity of the recorded subject and to
the order of the recording. Wilcoxon signed rank test
was used for comparisons of the total and median
number of IEDs and themedian inter-spike interval in
the different activity stages before VNS initiation,
and 3 and 9 months later. In order to investigate
possible changes in the variability of the inter-spike
intervals, the standard deviation of the inter-spike
intervals was calculated for each patient before VNS
initiation and 3 and 9 months after. Wilcoxon signed
rank test was also used for comparison of total and
median number and duration of seizures during the
24 h monitoring before VNS initiation and 3 and 9
months later. A binomial test was used in order to
check concordance in direction of changes in IEDs and
electrographic seizures during the 24 hmonitoring at
baseline and 9 months of VNS stimulation. Spearman
rank correlation coefficient (r) was used to calculate
the correlation between extent of reduction in IEDs
and seizure frequency, and improvement in seizure
severity and improvement in QOL. The level of sig-
nificance was set at p < 0.05.Results
Interictal epileptiform activity
The epileptiform activity consisted of focal or multi-
focal spike or sharp-wave complexes in 14 children.
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Table 1 Descriptive statistics of the pilot study between visual inspection and Persyst1 spike detector system.
Visual spike detection
(spikes/h)
Persyst1 spike detection
(spikes/h)
Difference between
visual and Persyst1 spike
detection (spikes/h)
Range (min—max) 0—1856 0—1885 29—78
Median 61 58 3
Quartiles (25th, 75th) 7.5, 91.5 7, 84 0, 14
Figure 1 Total number of detected spikes in 15 children
initially, andafter 3and9monthsofvagusnerve stimulation
(p = 0.03 at 9 months). Patients number 6 and 15 with
CSWS, a therapy resistant, neurophysiologic, and clinical
entity with epileptiform activity in>85% of non-REM sleep,
did not influence the comprehensive results of the group.One child had generalised spike-and-slow-waves. In
three children the epileptiform activity was sparse
and appeared as solitary discharges. In seven chil-
dren it was abundant, and in two more than 85% of
non-REM-sleep consisted of epileptiform activity,
they were classified as continuous spike-wave dis-
charges during slow sleep (CSWS).
The pilot study
The pilot study showed a high correlation between
the visual inspection and Persyst1 Spike Detector
system (PSDS) (r = 0.99). This suggests a low rate of
false positives in the visual inspection and that PSDS
tends to underestimate changes in epileptiform
activity. Proportionally, the PSDS never underesti-
mated the visual inspection by more than 25%.
Wilcoxon signed rank test showed a systematic dif-
ference between the visual inspection and the Per-
syst1 Spike Detector system (p = 0.04). The
difference was never more than 78 spikes/h, and
in 50% never more than 14 spikes/h (quartiles 0 and
14) (Table 1). Of the 21 analyzed recordings, the
visual inspection and the PSDS scored identical in
five. In 12, the visual inspection scored higher, and in
four, lower.
EEG recording
On reviewing the baseline EEGs, it was found that
two children had CSWS. This is a typical, therapy-
resistant, neurophysiologic and clinical entity with
epileptiform activity in >85% of non-REM sleep.27
The further analysis is presented both with and
without these two children.
After 9 months of VNS stimulation, the total
number of epileptiform discharges was significantly
reduced ( p = 0.03 in the 13 children without CSWS
and p = 0.04 in all 15 children) (Fig. 1). When con-
sidering the four activity stages separately, there
was a tendency towards reduction of median num-
ber of spikes in all stages, and significantly so in REM
( p = 0.03) and delta sleep (p = 0.02) in the 13 chil-
dren without CSWS (Table 2). See also Table 2 for
results in all 15 children. The total electrographic
seizure number was significantly reduced in the 24 h
of EEG monitoring at both 3 and 9 months (p = 0.03,0.05) in the 13 children without CSWS. In all 15
children p = 0.07 and 0.13 at 3 and 9 months. There
was a non-significant tendency of reduction of sei-
zure time.
In the 24 h of EEG monitoring there was a sig-
nificant concordance in direction of changes in epi-
leptiform activity and electrographic seizures at 9
months in 12 children. Three children did not have
any electrographic seizures, and could not contri-
bute to the analysis (p = 0.04) (Fig. 2). Ten children
had concordant changes. Eight showed a decrease in
both IEDs and seizure number, seven also in seizure
time. Two children showed increased IEDs, seizure
number and seizure duration. There was no direct
correlation between the extent of electrographic
seizure reduction and the degree in IED reduction
(r = 0.28, p > 0.3).
As we have reported, there was a reduction of
clinical seizures at three (median 65%) and 9 months
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Table 2 Results of spike detection in 1 h of wake, REM-, spindle- and delta-sleep, before VNS-initiation (baseline), 3
and 9 months after initiation.
Activity stage Before initiation (baseline) 3 months after initiation 9 months after initiation
Median (range) Median (range)/p-value Median (range)/p-value
13 Children, including two with CSWS
Wake 50.5 (0—2115) 49 (0—1999)/0.64 39 (0—2182)/0.67
ss 515 (0—3839) 189 (2—4827)/0.17 463 (3—3330)/0.3
REM 95 (1—2445) 75 (0—2216)/0.08 46 (0—1688)/0.03
Delta 550 (0—3176) 209 (3—2174)/0.10 155 (2—1295)/0.02
Total 968 (2—8133) 636 (8—6795)/0.15 636 (9.5—4802)/0.03
15 Children, including two with CSWS
Wake 91 (0—2115) 87 (0—1999)/0.68 44 (0—2182)/0.79
ss 515 (0—3839) 189 (2—4827)/0.17 463 (3—3330)/0.3
REM 215 (1—2445) 79 (0—2216)/0.16 68 (0—2034)/0.08
Delta 599 (0—5634) 264 (3—5678)/0.08 269 (2—4819)/0.008
Total 989 (2—10430) 643 (8—12795)/0.23 809 (9—11923)/0.04
CSWS: continuous spike-wave discharges during slow sleep.(median 63%), and a significant improvement in
NHS3 and QOL in the 15 children.26 Concordance
in direction of changes was seen in 9 of 15 children
between clinical seizures and IED ( p > 0.3), in10 of
15 children between QOL and IED ( p = 0.3) and in 8
of 15 children between NHS3 and IED ( p > 0.3).
There was no direct correlation between the extent
of improvement in these clinical data and the
degree of spike reduction (Spearman: r = 0.15,
0.04, 0.018. p > 0.3).
No significant changes of median inter-spike
interval were found at 3 and 9 months (p = 0.27,Figure 2 Concordance between changes in interictal
epileptiform discharges (IED) and electrographic seizures
during the 24 hmonitoring at 9months ( p = 0.04). The two
patients with continuous spike-wave discharges during
slow sleep (CSWS) are marked in the figure.0.10. In wake p = 0.58, 0.16; in ss p = 0.43, 0.86; in
REM p = 0.09, 0.14 and in delta sleep p = 0.43, 0.07).
In delta sleep there was a significant increase in the
standard deviation of inter-spike interval at 3 and 9
months, indicating that VNS produces more variable
spike patterns at this sleep stage ( p = 0.04, 0.03).
Overall, the standard deviation was high in compar-
ison to the median ISI.Discussion
In the present study 24-h EEG recordings were per-
formed in order to select long artefact-free record-
ings with comparable periods during the same real
time of day, activity stage and in the natural envir-
onment. Efforts were made to select accurate over-
night sleep recordings for quantification of sleep.
Taking these factors into account, a comparison of
the EEG in a particular patient would be more
accurate.
The pilot study showed a systematic difference
between the visual detection and the Persyst, auto-
mated spike-detection. The Persyst, automated
spike-detection tends to underestimate changes in
epileptiform activity. The observation that the auto-
mated spike detection has a higher false negative
detection rate with high IED frequencies than with
low frequencies may indicate that the effect of VNS
on IEDs was somewhat underestimated. The analysis
is presented both with and without the two children
with CSWS, due to the difficulties in distinguishing
between seizures and IEDs in this therapy-resistant
syndrome. One of these children showed an
increase, and the other a decrease in electrographic
seizures and in IEDs in all sleep stages with VNS.
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the group (Fig. 1).
The total number of epileptiform discharges was
significantly reduced after 9 months of VNS stimula-
tion. There was a trend towards smaller median
value in all sleep stages, but this was only significant
in REM and delta sleep. The total electrographic
seizure number was significantly reduced in the 24 h
EEG monitoring at both 3 and 9 months. These
findings are in agreement with previous animal
studies on VNS.12,13 So far, our findings are not
previously and consistently reported in human stu-
dies.14,15 This could be explained by longer and
more comprehensive recording, including different
activity stages in our study. Another possible expla-
nation is that, contrary to other studies, we only
investigated children.
In pharmacological studies, concomitant suppres-
sion of seizures and IEDs has been demonstrated in
generalized epilepsy.28 For partial epilepsies the
relationship is more controversial.29 Lamotrigine
and levetiracetam have been shown to reduce
IEDs.30,31 Clonazepam, diazepam, phenobarbital
and phenytoin show a correlation between suppres-
sion of IEDs and anti-epileptic drug plasma concen-
tration, while carbamazepine and valproate show
variable correlation.32—37 So far, few long-term
studies have investigated this possible relationship
between electrographic seizures and IED, especially
in children.
In the 12 children with electrographic seizures in
the 24-h EEG monitoring, there was a significant
concordance in direction of changes in interictal
epileptiform activity and electrographic seizures at
9 months. In our long-term data for all 15 children,
there was no concordance in direction of changes in
epileptiform activity and clinical effects on seizure
reduction, seizure severity and quality of life, and
there was no direct correlation between the extent
of improvement in these clinical data and the
degree of spike reduction. These data are in agree-
ment with the literature, which has suggested that
EEG IEDs are not directly related to clinical seizure
frequency.29 The method commonly used for eva-
luation of the anti-epileptic effect in children with
epilepsy is parents’ seizure frequency reports.
These are uncertain measures with a high rate of
missed subtle seizures and undetected seizures
during sleep. This could explain the lower concor-
dance between IEDs and clinical seizures compared
to IEDs and electrographic seizures during the 24 h
EEG.
The concomitant reduction in IEDs, electrographic
seizures and toa lesserextent in clinical seizures seen
in our study, indicate that VNS influences the epilep-
tic process at different functional levels.The persistence of the anticonvulsant effects and
the gradual decrease in epileptiform discharges and
electrographic seizure number in our study could
suggest that VNS induces long-term neuron-modu-
lating effects. Marrosu et al.38 recently described,
in an Iomazenil SPECTstudy on 10 subjects, that the
anti-epileptic action of VNS, although probably
multi-factorial, might be an increase in GABA-
mediated cortical inhibition. They showed a signifi-
cant correlation between VNS seizure reduction and
normalization of GABA receptor density. Besides this
long-term effect, the possible favourable direct VNS
effects that might suppress both spikes and seizures
could be mediated through different mechanisms,
such as arousal-like effects via the reticular activat-
ing system39—41 or sleep mechanisms and altered
background activity of EEG with arousals or direct
mood-elevating effects of VNS. The data from
Binnie,22 that interictal epileptiform activity with-
out any clinical signs is associated with transitory
cognitive disturbances, might suggest that a sup-
pression of IED in VNS is related to an improvement
in QOL. Further analyses of our recordings focusing
on sleep and background frequency and arousal
effects of VNS will be reported separately.
The high standard deviation in comparison with
the median ISI indicates large variation in ISI length.
This complicates the analysis of the VNS on ISI.
In conclusion we see a reduction in epileptiform
activity particularly in REM and delta sleep and a
reduction in the number of electrographic seizures.
In the 12 children with epileptiform activity and
electrographic seizures, we show a concordance
between reduction in IEDs and electrographic sei-
zures. The VNS effects on IEDs as well as on seizures
indicate that VNS affects the epileptic pathophysio-
logical process on different functional levels.Acknowledgments
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